EUVIMEDObjevte EUVIMED
Open access

Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome

Vishal A Manickam iD, Carly E Kimpling, Khoi N Le, Madeleine E Troussé iD, Amy Kang, Aarsh S Patel, Leslie W Chan iD

Science Advances · 2026-08-14 · 12 (33)

DOI: 10.1126/sciadv.aee2632 ↗

At a glance

Journal article in Science Advances, published on 2026-08-14. Written by Vishal A Manickam and 6 co-authors. Institution: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. Major MEDLINE topics: Gastrointestinal Microbiome, Glucuronidase, Microbiota. 68 references. The full text is freely available in PubMed Central. Funded by: NIBIB NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Due to their effects on drug activity and safety, drug-metabolizing enzymes (DMEs) from the gut microbiome are attractive drug targets, and noninvasive strategies are needed to measure their activities. Here, we report the development of ingestible probes that sense and produce breath signals for β-glucuronidase (GUS), a microbiome DME that causes drug toxicity. GUS probes comprise safe-to-ingest components and release volatile reporters upon cleavage by GUS. After oral administration, probes transit the gastrointestinal tract intact until they reach the microbiome in the large intestine. There, probes are cleaved by GUS and release volatile reporters, which are rapidly exhaled to provide a near real-time breath signal for GUS activity that can be measured via mass spectrometry. In mouse studies, breath signals were produced in naïve mice with GUS-expressing microbiome but absent in microbiome-depleted mice. Repeated probe dosing and breath analysis enabled monitoring of dynamic changes in GUS activities.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeGlucuronidaseMicrobiotaAnimalsBreath TestsMiceHumansAdministration, Oral

Substances

Glucuronidase

Authors and institutions

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
  • Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.

ORCID profiles: Vishal A Manickam, Madeleine E Troussé, Leslie W Chan

Funding

  • NIBIB NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institute of Biomedical Imaging and Bioengineering
  • Georgia Tech President’s Undergraduate Research Award

Cite

APA

Manickam, V. A., Kimpling, C. E., Le, K. N., Troussé, M. E., Kang, A., Patel, A. S., & Chan, L. W. (2026). Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome. Science Advances, 12(33). https://doi.org/10.1126/sciadv.aee2632

Vancouver

Manickam VA, Kimpling CE, Le KN, Troussé ME, Kang A, Patel AS, et al. Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome. Science Advances. 2026;12(33). doi:10.1126/sciadv.aee2632

BibTeX
@article{Manickam2026,
  author = {Manickam, Vishal A and Kimpling, Carly E and Le, Khoi N and Troussé, Madeleine E and Kang, Amy and Patel, Aarsh S and Chan, Leslie W},
  title = {Ingestible probes for breath-based monitoring of drug-metabolizing activity from the microbiome},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {33},
  doi = {10.1126/sciadv.aee2632}
}
Start for free →